| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $30.39K | $32.55K | $40.07K | $36.26K | $28.77K | $6.06M |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | $40.07K | $36.26K | $28.77K | $6.06M |
| Operating Income | -$30.39K | -$32.55K | -$40.07K | -$36.26K | -$28.77K | -$6.06M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Net Income | -$30.39K | -$32.55K | -$40.07K | -$36.26K | -$28.77K | -$6.06M |
| EPS (basic) | – | – | 0.0000 | 0.0000 | -0.2800 | -58.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | – | – | – |
| Shares (diluted) | $100.10M | $100.10M | $100.10M | – | – | – |